ADVFN - Advanced Financial Network.
HOME» NYSE » B » BSX Stock Price » BSX Stock News

Boston Scientific Share News

 Boston Scientific Corp. Stock Price
BSX Stock Price
 Boston Scientific Corp. Stock Chart
BSX Stock Chart
 Boston Scientific Corp. Stock News
BSX Stock News
 Boston Scientific Corp. Company Information
BSX Company Information
 Boston Scientific Corp. Stock Trades
BSX Stock Trades

Boston Scientific CEO Kucheman's 2011 Total Pay Rose 47% To $4.7 Million

By Anjali Athavaley Of DOW JONES NEWSWIRES NEW YORK -(Dow Jones)- Boston Scientific Corp. (BSX) Chief Executive William H. Kucheman's total pay jumped 47% to $4.7 million last year after he was named interim head of the Natick, Mass., medical-device maker. President Michael F. Mahoney, Kucheman's eventual replacement, received total compensation valued at $11.7 million last year, according to a filing Thursday with the Securities & Exchange Commission. Last fall, the company named Mahoney, previously the world-wide chairman of rival Johnson & Johnson's (JNJ) medical device and diagnostics group, as its new CEO in a complicated arrangement. Under the plan, Mahoney joined Boston Scientific as president in October and is expected to become CEO Nov. 1 this year. Kucheman, formerly president of the company's cardiology, rhythm and vascular group, is serving as interim CEO until then. Boston Scientific said in a regulatory filing last fall Mahoney would get an annual salary of $900,000 plus a sign-on bonus of $1.5 million and an additional bonus of $750,000 to be paid within 30 days following his promotion to president and CEO. He also would receive $9.5 million in deferred stock. As interim CEO, Kucheman would receive an annual salary of $900,000, the company has said. Shares were unchanged after-hours after closing up 3.5% at $5.93 Thursday. -By Anjali Athavaley, Dow Jones Newswires; 212-416-4912; anjali.athavaley@dowjones.com

Stock News for Boston Scientific (BSX)
DateTimeHeadline
08/26/201508:30:00Boston Scientific To Participate In The 2015 Wells Fargo Healthcare...
08/24/201516:30:00Boston Scientific Announces CE Mark For MRI Compatible Labeling...
08/24/201516:07:02Statement of Changes in Beneficial Ownership (4)
08/20/201516:07:16Statement of Changes in Beneficial Ownership (4)
08/19/201516:45:00Boston Scientific Announces FDA Approval of Innova™ Vascular S...
08/18/201516:07:59Statement of Changes in Beneficial Ownership (4)
08/11/201516:08:24Statement of Changes in Beneficial Ownership (4)
08/06/201516:16:15Quarterly Report (10-q)
08/04/201516:04:57Statement of Changes in Beneficial Ownership (4)
08/04/201509:13:19Current Report Filing (8-k)
08/04/201507:00:00Endo Completes Divestiture of American Medical Systems' Men's...
08/04/201507:00:00Boston Scientific Closes Acquisition Of The American Medical...
08/04/201507:00:00Endo Completes Divestiture of American Medical Systems' Men's...
08/03/201517:08:00Boston Scientific Announces Equity Investment And Sales Cooperation...
08/03/201516:30:00Boston Scientific Announces Equity Investment And Sales Cooperation...
07/23/201507:10:17Current Report Filing (8-k)
07/23/201507:00:00Boston Scientific Announces Results For Second Quarter 2015
07/20/201509:00:00Boston Scientific Initiates Study Evaluating New Fully Resorbable...
07/16/201516:09:04Initial Statement of Beneficial Ownership (3)
07/15/201509:14:05Current Report Filing (8-k)

Boston Scientific and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad